The Impact of Bundled Payments for Cardiopulmonary Disease on High-Risk Populations
心肺疾病捆绑支付对高危人群的影响
基本信息
- 批准号:9917818
- 负责人:
- 金额:$ 79.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsBackCardiopulmonaryCaringCase MixesChronicChronic Obstructive Airway DiseaseClinicalComplexDataElderlyHealthcare SystemsHeart failureHospitalsIncentivesInterventionLearningMeasuresMedicalMedicareMedicare/MedicaidModelingMyocardial InfarctionOperative Surgical ProceduresOutcomeParticipantPatient-Focused OutcomesPatientsPatternPerformancePhysiciansPneumoniaPoliciesPopulationProgram EvaluationProviderPulmonary Heart DiseaseQuality of CareRecommendationReplacement ArthroplastyReportingResearchRiskSavingsSepsisServicesSurveysTestingTimeUpdateWorkacute careadverse outcomebundled paymentcare costscare episodecare providerscostdesignexperiencefinancial incentivehigh riskhigh risk populationhospital readmissionimprovedinnovationmultiple chronic conditionspaymentprogramssafety netsocialsocial health determinantssuccess
项目摘要
Abstract
Our health care system is fragmented, which leads to suboptimal outcomes for high-risk populations with
chronic conditions, such as cardiopulmonary disease, combined with complex medical or social needs.
Bundled payments are an alternative payment model (APM) that incents efficiency by holding providers
accountable for costs and quality across an entire episode of care. The Center for Medicare and Medicaid
Innovation (CMMI) launched the Bundled Payments for Care Improvement (BPCI) initiative in 2013; a new
version of this program, BPCI-Advanced (BPCI-A), replaces BPCI in October 2018. Under both, participants
that meet cost targets keep the savings, while those that fail to do so pay Medicare back the difference. BPCI-
A has increased the financial incentives and added quality measures to further incentivize improvements.
Bundled payments provide strong incentives for providers to better-coordinate services and redesign care,
which could be very helpful for medically or socially high-risk older adults. These are populations for which
clinical innovations are sorely needed, and knowing which ones are being tried and appear to be working could
be very helpful in improving quality of care. On the other hand, bundled payments could induce providers to
avoid those patients or skimp on care, which could result in poor outcomes. Our overarching hypothesis is that
the financial incentives in BPCI had adverse consequences in high-risk cardiopulmonary patients, while the
enhanced incentives and use of quality measures in BPCI-A will reduce some of those consequences.
Quantifying the impact of BPCI-A on high-risk populations is critically important as Medicare and other payers
increasingly shift towards these and other alternative payment models. Examining a variety of medical and
surgical cardiopulmonary conditions that represent a range of acuity and complexity, our aims are to 1) Using
claims data, determine how BPCI and BPCI-A impact cardiopulmonary spending, access, and outcomes for
medically and socially high-risk populations; 2) Using a national survey, identify predictors of participation in
BPCI-A, and key approaches to care redesign; and 3) Combining claims and survey data, determine patient,
hospital, market, and strategic predictors of success under BPCI-A.
Our proposed work will provide timely information to inform annual updates to BPCI-A, and identify clinical
interventions that are strong candidates to improve cardiopulmonary care for all patients. Such work could help
to protect and optimize outcomes among high-risk populations. Absent these findings and the resulting policy
recommendations, BPCI-A could have unintended adverse consequences.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen Ellen Joynt Maddox其他文献
Karen Ellen Joynt Maddox的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen Ellen Joynt Maddox', 18)}}的其他基金
Rural-Urban Disparities In Spillover Effects of COVID-19
COVID-19 溢出效应的城乡差异
- 批准号:
10523385 - 财政年份:2022
- 资助金额:
$ 79.15万 - 项目类别:
Rural-Urban Disparities In Spillover Effects of COVID-19
COVID-19 溢出效应的城乡差异
- 批准号:
10612486 - 财政年份:2022
- 资助金额:
$ 79.15万 - 项目类别:
The Impact of Bundled Payments for Cardiopulmonary Disease on High-Risk Populations
心肺疾病捆绑支付对高危人群的影响
- 批准号:
10399472 - 财政年份:2019
- 资助金额:
$ 79.15万 - 项目类别:
THE IMPACT OF PUBLIC REPORTING ON OUTCOMES AND CASE SELECTION FOR PCI
公开报告对 PCI 结果和案例选择的影响
- 批准号:
9522363 - 财政年份:2017
- 资助金额:
$ 79.15万 - 项目类别:
The Impact of Public Reporting on Outcomes and Case Selection for PCI
公开报告对 PCI 结果和案例选择的影响
- 批准号:
8698455 - 财政年份:2011
- 资助金额:
$ 79.15万 - 项目类别:
The Impact of Public Reporting on Outcomes and Case Selection for PCI
公开报告对 PCI 结果和案例选择的影响
- 批准号:
8322556 - 财政年份:2011
- 资助金额:
$ 79.15万 - 项目类别:
The Impact of Public Reporting on Outcomes and Case Selection for PCI
公开报告对 PCI 结果和案例选择的影响
- 批准号:
8508301 - 财政年份:2011
- 资助金额:
$ 79.15万 - 项目类别:
The Impact of Public Reporting on Outcomes and Case Selection for PCI
公开报告对 PCI 结果和案例选择的影响
- 批准号:
8165932 - 财政年份:2011
- 资助金额:
$ 79.15万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 79.15万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 79.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 79.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 79.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 79.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 79.15万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 79.15万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 79.15万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 79.15万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 79.15万 - 项目类别:
Studentship